Predicting inhibitory and activatory drug targets by chemically and genetically perturbed transcriptome signatures
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Predicting inhibitory and activatory drug targets by chemically and genetically perturbed transcriptome signatures
Authors
Keywords
-
Journal
Scientific Reports
Volume 8, Issue 1, Pages -
Publisher
Springer Nature
Online
2018-01-03
DOI
10.1038/s41598-017-18315-9
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The use of calcium and vitamin D in the management of osteoporosis
- (2016) John Sunyecz Therapeutics and Clinical Risk Management
- Predicting target proteins for drug candidate compounds based on drug-induced gene expression data in a chemical structure-independent manner
- (2015) Yoshiyuki Hizukuri et al. BMC Medical Genomics
- Systematic Drug Repositioning for a Wide Range of Diseases with Integrative Analyses of Phenotypic and Molecular Data
- (2015) Hiroaki Iwata et al. Journal of Chemical Information and Modeling
- Target-Based Drug Repositioning Using Large-Scale Chemical–Protein Interactome Data
- (2015) Ryusuke Sawada et al. Journal of Chemical Information and Modeling
- Retinoic acid receptors: From molecular mechanisms to cancer therapy
- (2015) Alessandra di Masi et al. MOLECULAR ASPECTS OF MEDICINE
- Phenotypic screening in cancer drug discovery — past, present and future
- (2014) John G. Moffat et al. NATURE REVIEWS DRUG DISCOVERY
- LINCS Canvas Browser: interactive web app to query, browse and interrogate LINCS L1000 gene expression signatures
- (2014) Qiaonan Duan et al. NUCLEIC ACIDS RESEARCH
- Target identification and mechanism of action in chemical biology and drug discovery
- (2013) Monica Schenone et al. Nature Chemical Biology
- ABT-199, a potent and selective BCL-2 inhibitor, achieves antitumor activity while sparing platelets
- (2013) Andrew J Souers et al. NATURE MEDICINE
- Therapeutic target database update 2014: a resource for targeted therapeutics
- (2013) Chu Qin et al. NUCLEIC ACIDS RESEARCH
- Drug Repositioning by Kernel-Based Integration of Molecular Structure, Molecular Activity, and Phenotype Data
- (2013) Yongcui Wang et al. PLoS One
- Prediction of Drug-Target Interactions for Drug Repositioning Only Based on Genomic Expression Similarity
- (2013) Kejian Wang et al. PLoS Computational Biology
- A co-module approach for elucidating drug–disease associations and revealing their molecular basis
- (2012) Shiwen Zhao et al. BIOINFORMATICS
- Drug target prediction using adverse event report systems: a pharmacogenomic approach
- (2012) M. Takarabe et al. BIOINFORMATICS
- Modern Phenotypic Drug Discovery Is a Viable, Neoclassic Pharma Strategy
- (2012) Jonathan A. Lee et al. JOURNAL OF MEDICINAL CHEMISTRY
- Study of drug function based on similarity of pathway fingerprint
- (2012) Hao Ye et al. Protein & Cell
- Predicting drug side-effect profiles: a chemical fragment-based approach
- (2011) Edouard Pauwels et al. BMC BIOINFORMATICS
- An Algorithmic Framework for Predicting Side Effects of Drugs
- (2011) Nir Atias et al. JOURNAL OF COMPUTATIONAL BIOLOGY
- PREDICT: a method for inferring novel drug indications with application to personalized medicine
- (2011) A. Gottlieb et al. Molecular Systems Biology
- How were new medicines discovered?
- (2011) David C. Swinney et al. NATURE REVIEWS DRUG DISCOVERY
- ChEMBL: a large-scale bioactivity database for drug discovery
- (2011) A. Gaulton et al. NUCLEIC ACIDS RESEARCH
- Systematic Drug Repositioning Based on Clinical Side-Effects
- (2011) Lun Yang et al. PLoS One
- Drug-target interaction prediction from chemical, genomic and pharmacological data in an integrated framework
- (2010) Y. Yamanishi et al. BIOINFORMATICS
- Cooperative interaction between retinoic acid receptor- and estrogen receptor in breast cancer
- (2010) C. S. Ross-Innes et al. GENES & DEVELOPMENT
- DrugBank 3.0: a comprehensive resource for 'Omics' research on drugs
- (2010) C. Knox et al. NUCLEIC ACIDS RESEARCH
- Discovery of drug mode of action and drug repositioning from transcriptional responses
- (2010) F. Iorio et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Analysis of adverse drug reactions using drug and drug target interactions and graph-based methods
- (2009) Shih-Fang Lin et al. ARTIFICIAL INTELLIGENCE IN MEDICINE
- Chelation of intracellular iron with the antifungal agent ciclopirox olamine induces cell death in leukemia and myeloma cells
- (2009) Y. Eberhard et al. BLOOD
- Genomic Antagonism between Retinoic Acid and Estrogen Signaling in Breast Cancer
- (2009) Sujun Hua et al. CELL
- Systematic Evaluation of Drug–Disease Relationships to Identify Leads for Novel Drug Uses
- (2009) A P Chiang et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Identifying Network of Drug Mode of Action by Gene Expression Profiling
- (2009) Francesco Iorio et al. JOURNAL OF COMPUTATIONAL BIOLOGY
- Predicting new molecular targets for known drugs
- (2009) Michael J. Keiser et al. NATURE
- KEGG for representation and analysis of molecular networks involving diseases and drugs
- (2009) Minoru Kanehisa et al. NUCLEIC ACIDS RESEARCH
- Human Disease-Drug Network Based on Genomic Expression Profiles
- (2009) Guanghui Hu et al. PLoS One
- Protein-ligand interaction prediction: an improved chemogenomics approach
- (2008) Laurent Jacob et al. BIOINFORMATICS
- Prediction of drug-target interaction networks from the integration of chemical and genomic spaces
- (2008) Y. Yamanishi et al. BIOINFORMATICS
- Drug Target Identification Using Side-Effect Similarity
- (2008) M. Campillos et al. SCIENCE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started